NCT04558567View on ClinicalTrials.gov

Vogelxo(R) ABPM Study in Hypogandal Men

PHASE4CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

August 28, 2020

Primary Completion Date

December 12, 2023

Study Completion Date

January 11, 2024

Conditions
Hypogonadism, Male
Interventions
DRUG

Vogelxo

50mg (1 tube, 5g gel) to 100mg (2 tubes, 10g gel)

Trial Locations (7)

11530

Upsher-Smith Clinical Trials Site #7, Garden City

29405

Upsher-Smith Clinical Trials Site #4, North Charleston

33153

Upsher-Smith Clinical Trial Site #1, Miami

35235

Upsher-Smith Clinical Trial Site #6, Birmingham

78229

Upsher-Smith Clinical Trials Site #5, San Antonio

78744

Upsher-Smith Clinical Trials Site #8, San Antonio

92801

Upsher-Smith Clinical Trial Site #2, Anaheim

All Listed Sponsors
lead

Upsher-Smith Laboratories

INDUSTRY

NCT04558567 - Vogelxo(R) ABPM Study in Hypogandal Men | Biotech Hunter | Biotech Hunter